Literature DB >> 18483472

Current status and characteristics of hypertension treatment by primary physicians in Korea: data from Korean epidemiology study on hypertension (KEY study).

Kwang-Il Kim1, Yooni Kim, Hee-Jin Kim, Duk-Hyun Kang, Jeong Bae Park, Dong-Ju Choi, Cheol-Ho Kim.   

Abstract

BACKGROUND: This study was designed to investigate the characteristics, control rate, and factors affecting BP control in hypertensive patients treated by primary physicians in Korea.
METHODS: The study was a multicenter, nationwide, cross-sectional, population-based survey conducted to identify the current status of hypertension treatment in Korean patients. A direct mail survey was sent to a random sample of 800 primary-care clinics across the nation. A total of 529 physicians in 510 clinics agreed to participate in this study (63.8%). Among the recruited 13,452 patients, 13,184 were included in the analysis.
RESULTS: BP was controlled in 6,723 patients (51.0%). However, the control rate was lower in patients with diabetes (21.6%) or chronic kidney disease (CKD) (19.9%). Furthermore, the mean systolic and diastolic BP levels were higher in patients with diabetes and/or CKD. The mean BP level was higher in patients undergoing combination therapy than those undergoing single-drug therapy. Male gender, cardiovascular comorbidities, long duration of hypertension, and unhealthy lifestyle were associated with poor control of hypertension. In multivariate analysis, diabetes (odds ratio: 5.57; 95% confidence interval: 5.05-6.13) and CKD (odds ratio: 3.40; 95% confidence interval: 2.54-4.54) were the most significant independent factors related to poor BP control.
CONCLUSION: BP control is still largely unsatisfactory, especially in patients with diabetes and kidney disease, who could benefit the most from effective BP control. The reasons for poor BP control and high BP levels in those patients need to be investigated to improve BP control in Korea.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18483472     DOI: 10.1038/ajh.2008.191

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  12 in total

1.  The healthcare burden of hypertension in Asia.

Authors:  Chun-Na Jin; Cheuk-Man Yu; Jing-Ping Sun; Fang Fang; Yong-Na Wen; Ming Liu; Alex Pui-Wai Lee
Journal:  Heart Asia       Date:  2013-11-19

Review 2.  Men's health in South Korea.

Authors:  Sae-Chul Kim; Sang Wook Kim; Yun Jae Chung
Journal:  Asian J Androl       Date:  2011-04-11       Impact factor: 3.285

Review 3.  Prevalence and treatment rate of osteoporosis in patients undergoing total knee and hip arthroplasty: a systematic review and meta-analysis.

Authors:  Pei-Lun Xiao; Chi-Jen Hsu; Yong-Guang Ma; Ding Liu; Rong Peng; Xiang-He Xu; Hua-Ding Lu
Journal:  Arch Osteoporos       Date:  2022-01-14       Impact factor: 2.617

4.  Understanding the rapid increase in life expectancy in South Korea.

Authors:  Seungmi Yang; Young-Ho Khang; Sam Harper; George Davey Smith; David A Leon; John Lynch
Journal:  Am J Public Health       Date:  2010-03-18       Impact factor: 9.308

5.  Ten-year trends of hypertension treatment and control rate in Korea.

Authors:  Kwang-Il Kim; Eunjeong Ji; Jung-Yeon Choi; Sun-Wook Kim; Soyeon Ahn; Cheol-Ho Kim
Journal:  Sci Rep       Date:  2021-03-26       Impact factor: 4.379

6.  Effect of Lacidipine on Blood Pressure and Endothelial Function in Mild-to-Moderate Essential Hypertension Patients With Diabetes in Korea.

Authors:  Dae-Hee Kim; Il-Young Oh; Hae-Young Lee; Yong-Jin Kim; Hyo-Soo Kim; Cheol-Ho Kim; Byung-Hee Oh; Kwon-Sam Kim; Doo-Il Kim; Young-Dae Kim; Kyu-Hyung Ryu; Si-Hoon Park; Sang-Hong Baek; Dong-Gu Shin; Wan Joo Shim; Tae-Hoon Ahn; Seok-Kyu Oh; Seung-Hwan Lee; Sung-Yun Lee; Myung-Ho Jeong; Wook-Sung Chung; Jun-Young Jeong; So-Yeon Choi; Si-Wan Choi; Min-Su Hyon
Journal:  Korean Circ J       Date:  2010-12-31       Impact factor: 3.243

7.  Telmisartan versus valsartan in patients with hypertension: effects on cardiovascular, metabolic, and inflammatory parameters.

Authors:  Sung Yoon Lim; Sun Won Kim; Eung Ju Kim; Jun Hyuk Kang; Su A Kim; Yun Kyung Kim; Jin Oh Na; Cheol Ung Choi; Hong Euy Lim; Seong Woo Han; Seung-Woon Rha; Chang Gyu Park; Hong Seog Seo; Dong Joo Oh
Journal:  Korean Circ J       Date:  2011-10-31       Impact factor: 3.243

8.  Effects of drug price reduction and prescribing restrictions on expenditures and utilisation of antihypertensive drugs in Korea.

Authors:  Ki-Bong Yoo; Sang Gyu Lee; Sohee Park; Tae Hyun Kim; Jeonghoon Ahn; Mee-Hyun Cho; Eun-Cheol Park
Journal:  BMJ Open       Date:  2015-07-15       Impact factor: 2.692

9.  The relationship between hypertension and sleep duration: an analysis of the fifth Korea National Health and Nutrition Examination Survey (KNHANES V-3).

Authors:  Hye-Rim Hwang; Jeong-Gyu Lee; Sangyeop Lee; Kwang Soo Cha; Jung Hyun Choi; Dong-Wook Jeong; Yu-Hyun Yi; Young-Hye Cho; Young-Jin Tak; Yun-Jin Kim
Journal:  Clin Hypertens       Date:  2015-06-11

10.  Efficacy and safety of azilsartan medoxomil, an angiotensin receptor blocker, in Korean patients with essential hypertension.

Authors:  Attila Juhasz; Jingtao Wu; Michie Hisada; Tomoka Tsukada; Myung Ho Jeong
Journal:  Clin Hypertens       Date:  2018-02-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.